We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.6M
AUM Growth
-$9.18M
Cap. Flow
-$6.23M
Cap. Flow %
-6.32%
Top 10 Hldgs %
86.36%
Holding
30
New
7
Increased
6
Reduced
3
Closed
6

Top Buys

Rank Stock Value
1
RDUS
Radius Health, Inc.
RDUS
+$2.6M
2
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$2.32M
3
QIPT
Quipt Home Medical
QIPT
+$1.39M
4
ALIM
Alimera Sciences
ALIM
+$1.03M
5
HCSG icon
Healthcare Services Group
HCSG
+$862K

Top Sells

Rank Stock Value
1
ATRS
Antares Pharma, Inc.
ATRS
+$5.52M
2
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
+$3.48M
3
LNTH icon
Lantheus
LNTH
+$3.24M
4
RAPT
RAPT Therapeutics
RAPT
+$2.42M
5
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$1.89M

Sector Composition

Rank Sector Weight
1 Healthcare 75.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSVT
26
DELISTED
2seventy bio
TSVT
– –
-23,657
Closed -$404K
VTRS icon
27
Viatris
VTRS
$18.5B
– –
-100,000
Closed -$1.09M
CMRX
28
DELISTED
Chimerix, Inc.
CMRX
– –
-400,000
Closed -$1.83M
SLGC
29
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
– –
-235,300
Closed -$1.89M
ATRS
30
DELISTED
Antares Pharma, Inc.
ATRS
– –
-1,346,971
Closed -$5.52M
1
2

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return

Velan Capital Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Velan Capital Investment Management held 30 positions worth $98.6M, down 8.5% from $108M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Velan Capital Investment Management withdrew a net $6.23M in Q2 2022, closing 6 positions and reducing 3 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $5.52M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 86% a quarter earlier.

Against the trend, Velan Capital Investment Management opened a new position in BioCryst Pharmaceuticals worth $2.38M.

  • Velan Capital Investment Management's largest Q2 2022 buy was BioCryst Pharmaceuticals: 225,000 shares worth $2.38M.
  • Velan Capital Investment Management added most to Radius Health, Inc. in Q2 2022, an estimated $2.6M increase.
  • Velan Capital Investment Management's biggest Q2 2022 reduction was Science 37 Holdings, Inc. Common Stock, cutting an estimated $3.48M.
  • Velan Capital Investment Management fully exited Antares Pharma, Inc. in Q2 2022, selling an estimated $5.52M.
  • Velan Capital Investment Management's ten largest holdings make up 86% of its $98.6M portfolio in Q2 2022.
  • Velan Capital Investment Management opened 7 new positions and closed 6 in Q2 2022.
  • Velan Capital Investment Management's portfolio value fell 8.5% quarter-over-quarter to $98.6M.

Based on Velan Capital Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.